ORASURE TECHNOLOGIES, INC.

OSUR · NASDAQ

Surgical and Medical Instrument Manufacturing · US

OraSure Technologies empowers the global community to improve health and wellness by providing access to accurate, essential information. OraSure, together with its wholly-owned subsidiaries, DNA Genotek, Diversigen, and Novosanis, provides its customers with end-to-end solutions that encompass tools, services and diagnostics. The OraSure family of companies is a leader in the development, manufacture, and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions designed to discover and detect critical medical conditions. OraSure's portfolio of products is sold globally to clinical laboratories, hospitals, physician's offices, clinics, public health and community-based organizations, research institutions, government agencies, pharma, commercial entities and direct to consumers.

Market Data

Price $3.13 -0.07 (-2.19%)

Market Cap—

P/E Ratio—

EPS$—

52W High$—

52W Low$—

Beta—

Data from Finnhub · Updated Mar 11, 2026